Primary hyperparathyroidism (PHPT) is a common endocrine disorder. However, a familial hyperparathyroid syndrome is diagnosed in less than five percent of cases. We present two related cases of CDC73-related familial hyperparathyroidism due to a rarely described germline Leu63Pro missense mutation in CDC73 exon 2.
CDC73-related familial hyperparathyroidism encompasses a spectrum of parathyroid disorders including the following phenotypes:
• hyperparathyroidism-jaw tumour syndrome (HPT-JT)
• Parathyroid carcinoma However despite treatment with cinacalcet, persistent severe symptomatic hypercalcaemia necessitated an urgent parathyroidectomy. All 4 parathyroid glands were excised. Her recovery was complicated by severe hungry bone syndrome.
The patient's parents are unaffected by hyperparathyroidism. However it transpired that her 35-year old brother had a history of resected Wilms' tumour aged 5. He also had PHPT with a left inferior parathyroid adenoma removed in 2008. Despite being initially lost to follow-up, he was subsequently re-referred with symptomatic recurrent PHPT (PTH 31.2 pmol/L, Ca 2.95mmol/L). He underwent repeat parathyroid surgery and one normally functioning parathyroid gland was left in-situ. In both cases, parathyroid histology was benign.
Further enquiry into the family history revealed that a paternal cousin also had hypercalcaemia and had more than one parathyroid glands removed. In addition, the paternal grandmother had also suffered from renal stones.
Genetic testing revealed germline Leu63Pro missense mutation in CDC73 exon 2, gene coding for the parafibromin protein. 
